COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $139,485,546 | +6.8% | 6,240,964 | +2.7% | 0.00% | 0.0% |
Q2 2023 | $130,623,075 | -6.3% | 6,078,319 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $139,429,614 | +4.8% | 5,811,989 | +1.4% | 0.00% | 0.0% |
Q4 2022 | $132,988,547 | +44.5% | 5,732,265 | -0.2% | 0.00% | +33.3% |
Q3 2022 | $92,006,000 | -8.1% | 5,743,130 | +1.6% | 0.00% | 0.0% |
Q2 2022 | $100,139,000 | -14.0% | 5,651,116 | -1.2% | 0.00% | 0.0% |
Q1 2022 | $116,403,000 | +10.7% | 5,717,305 | +1.5% | 0.00% | 0.0% |
Q4 2021 | $105,199,000 | -5.3% | 5,631,660 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $111,082,000 | -17.1% | 5,627,308 | -0.7% | 0.00% | -25.0% |
Q2 2021 | $133,959,000 | -4.0% | 5,666,627 | -3.7% | 0.00% | 0.0% |
Q1 2021 | $139,513,000 | +145.4% | 5,886,536 | +107.4% | 0.00% | +100.0% |
Q4 2020 | $56,850,000 | -2.8% | 2,838,217 | +1.1% | 0.00% | 0.0% |
Q3 2020 | $58,477,000 | +18.7% | 2,808,684 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $49,283,000 | +20.8% | 2,816,195 | +12.8% | 0.00% | 0.0% |
Q1 2020 | $40,784,000 | -22.8% | 2,497,426 | -2.7% | 0.00% | 0.0% |
Q4 2019 | $52,807,000 | +79.7% | 2,565,927 | +0.2% | 0.00% | +100.0% |
Q3 2019 | $29,385,000 | -10.2% | 2,559,618 | +2.9% | 0.00% | 0.0% |
Q2 2019 | $32,724,000 | -7.0% | 2,488,479 | +7.1% | 0.00% | -50.0% |
Q1 2019 | $35,178,000 | -21.8% | 2,323,461 | -11.3% | 0.00% | 0.0% |
Q4 2018 | $44,980,000 | +26.6% | 2,619,718 | +8.7% | 0.00% | 0.0% |
Q3 2018 | $35,517,000 | -33.9% | 2,409,573 | +7.0% | 0.00% | 0.0% |
Q2 2018 | $53,717,000 | +6.2% | 2,252,273 | +13.8% | 0.00% | 0.0% |
Q1 2018 | $50,588,000 | +39.4% | 1,979,971 | +0.7% | 0.00% | 0.0% |
Q4 2017 | $36,285,000 | +83.4% | 1,965,566 | +4.2% | 0.00% | +100.0% |
Q3 2017 | $19,785,000 | -14.6% | 1,886,100 | +1.9% | 0.00% | 0.0% |
Q2 2017 | $23,161,000 | +55.4% | 1,851,327 | +25.0% | 0.00% | 0.0% |
Q1 2017 | $14,902,000 | +165477.8% | 1,481,207 | +260675.9% | 0.00% | – |
Q4 2016 | $9,000 | -18.2% | 568 | 0.0% | 0.00% | – |
Q3 2016 | $11,000 | +57.1% | 568 | 0.0% | 0.00% | – |
Q2 2016 | $7,000 | -50.0% | 568 | -24.2% | 0.00% | – |
Q1 2016 | $14,000 | – | 749 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |